BioSpace News Archive

Business

TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2018

Total revenue of $6.4 million, including the sale of four Senhance Systems

August 7, 2018
·
15 min read
Business

Cerveau Technologies Inc. Announces Expanded Research Access to Novel Tau Imaging Agent

This expansion has been driven by the increasing interest in [18F]MK-6240 as a developmental and investigational tool in clinical trials.

August 7, 2018
·
1 min read
Business

TraceLink Joins Irish Medicines Verification Organization (IMVO) Serialization Pilot for Pharmacies and Clinics

TraceLink Inc announced that it has joined the Irish Medicines Verification Organization (IMVO) serialization pilot study and will support a number of hospitals, pharmacies and clinics connect to the Irish Medicines Verification System (IMVS).

August 7, 2018
·
4 min read
Drug Development

Frequency Therapeutics Initiates Phase 1/2 Single Dose Clinical Trial to Evaluate FX-322, a First-in-Class Drug Candidate for Hearing Restoration

Trial marks the first time a potential progenitor cell activator will be tested in adult patients with stable sensorineural hearing loss

August 7, 2018
·
5 min read
Biotech Bay

Credence MedSystems Closes $12.8 Million Series B Financing

Funding will support ongoing development and scaling of Credence’s family of innovative drug delivery products

August 7, 2018
·
2 min read
BioMidwest

Express Scripts Announces New Recommendations Tackling High Drug Prices

2019 National Preferred Formulary includes low list price medications in high-cost categories

August 7, 2018
·
5 min read
Business

Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer

Key Addition to Infinity’s Clinical Development Team Brings Recent Experience Leading First-in-Class, Targeted Oncology Programs Through FDA Approvals

August 7, 2018
·
4 min read
Business

ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance

Acquires WellSpring Pharma Services for $18 Million in Cash to Expand Contract Manufacturing Business and Accelerate ANDA Pipeline Re-commercialization Efforts Targets sNDA Filing for Cortrophin Gel by Q1 2020

August 7, 2018
·
47 min read
BioMidwest

Surmodics to Present at 7th Annual Intellisight Investor Conference

SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will participate in the 7th Annual Intellisight Conference.

August 7, 2018
·
1 min read
Business

Novus Therapeutics Reports Second Quarter 2018 Financial Results

The FDA confirmed that development of OP-02 for separate otitis media treatment and prevention indications would be acceptable.

August 7, 2018
·
7 min read